IL2RA and lymphoma: Binding assays demonstrated high anti-human 89Zr-CD25 IgG binding to SUDHL1 lymphoma cells that reached 34.2 and 32.0-fold increases over H9 cells and Jurkat cells, respectively (both P <0.001; Figure 2A).